You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers
|
|---|---|
| Published in |
Cancer Discovery, May 2018
|
| DOI | 10.1158/2159-8290.cd-17-1004 |
| Pubmed ID | |
| Authors |
Alexander Drilon, Romel Somwar, Biju P. Mangatt, Henrik Edgren, Patrice Desmeules, Anja Ruusulehto, Roger S. Smith, Lukas Delasos, Morana Vojnic, Andrew J. Plodkowski, Joshua Sabari, Kenneth Ng, Joseph Montecalvo, Jason Chang, Huichun Tai, William W. Lockwood, Victor Martinez, Gregory J. Riely, Charles M. Rudin, Mark G. Kris, Maria E. Arcila, Christopher Matheny, Ryma Benayed, Natasha Rekhtman, Marc Ladanyi, Gopinath Ganji |
X Demographics
The data shown below were collected from the profiles of 58 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 23 | 40% |
| Spain | 7 | 12% |
| Canada | 3 | 5% |
| Japan | 2 | 3% |
| United Kingdom | 2 | 3% |
| Mexico | 2 | 3% |
| France | 1 | 2% |
| Turkey | 1 | 2% |
| Hong Kong | 1 | 2% |
| Other | 2 | 3% |
| Unknown | 14 | 24% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 26 | 45% |
| Practitioners (doctors, other healthcare professionals) | 17 | 29% |
| Scientists | 12 | 21% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
| Unknown | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 142 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 142 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 30 | 21% |
| Other | 13 | 9% |
| Student > Bachelor | 10 | 7% |
| Student > Ph. D. Student | 8 | 6% |
| Student > Master | 8 | 6% |
| Other | 27 | 19% |
| Unknown | 46 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 26% |
| Biochemistry, Genetics and Molecular Biology | 27 | 19% |
| Agricultural and Biological Sciences | 10 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 6% |
| Unspecified | 2 | 1% |
| Other | 7 | 5% |
| Unknown | 51 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 62. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2024.
All research outputs
#705,937
of 25,775,807 outputs
Outputs from Cancer Discovery
#378
of 4,154 outputs
Outputs of similar age
#15,293
of 345,246 outputs
Outputs of similar age from Cancer Discovery
#8
of 67 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,154 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,246 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.